Skip to nav Skip to content

News

November 13, 2019

 All Issues
 Read the last issue of IDSA News Read the next issue of IDSA News 
CDC Issues Antimicrobial Resistance Threat Report

While recent federal investments to combat antibiotic resistance have had important impacts, antibiotic resistance remains a significant threat to patient safety and public health, according to a new report issued by the Centers for Disease Control and Prevention.

Read More
Meet Dr. Thomas File, Jr., FIDSA, IDSA’s New President

In case you missed it, Dr. Tom File posted the first video message of his term as president of IDSA’s Board of Directors. Learn about his career focus and what he looks forward to working on as the leader of the Society.

Read More
CMS Finalizes Revised E/M CPT® Codes for Office/Outpatient Visits

The Centers for Medicare and Medicaid Services released the 2020 Medicare Physician Fee Schedule and Quality Payment Program final rule on Nov. 1. What will this mean for you?

Read More
Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.

Isoniazid Preventive Therapy for HIV-Infected Pregnant Women: Start During Pregnancy or Postpartum? and Cryptococcal Mortality in the Modern ART Era

Read More
A Call for Gender Equity in HIV Prevention Drug Approvals

The U.S. Food and Drug Administration's decision to approve Descovy for PrEP with an exclusion for cisgender women was cause for concern among IDSA and HIVMA members.

Read More
IDSA Comments on Duodenoscope Sterilization at FDA Panel Meeting

The U.S. Food and Drug Administration recently convened a meeting of the Medical Devices Advisory Committee that included a discussion of the risks of infection with reprocessed duodenoscopes. IDSA weighed in with concerns and recommendations.

Read More
Science Speaks Covers the 50th Union World Conference on Lung Health

The 50th Union World Conference on Lung Health brought tuberculosis treatment advocates, physicians, scientists, policy makers, and the IDSA/HIVMA global Science Speaks blog to Hyderabad, India from Oct. 30 to Nov. 2.

Read More
Border Conditions are Set Up for Outbreaks, the Value of ID, and More in the News

Forbes spoke with IDSA spokespersons Drs. Betsy Herold, FIDSA, and Mark Travassos on the political battlefield of infections and migrant children’s bodies, an interview based on a recent article and accompanying editorial in Clinical Infectious Diseases.

Read More
ICYMI: What’s Hot on MyIDSA

Here’s a glance at the latest discussions happening on MyIDSA, IDSA’s members-only online community (login required).

Read More

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.